The Latest in Presbyopia: 2023 Paper Sessions
View the latest research on presbyopia correction by exploring these 2023 ASCRS Annual Meeting paper sessions.
New in CME 24/7: A Taste of ASCRS 2023
Experience the best of ASCRS education
Join program co-chairs and faculty for an online CME 24/7 activity where you’ll gain pearls you can put into practice on day one. Captured at the 2023 ASCRS Summer Meeting, this program is designed to offer a "taste" of the best education ASCRS has to offer.
Earn up to 10 AMA PRA Category 1 Credits™ by participating in the nine sections in this online program.Learn More
X-Rounds: My Favorite Treatment for Presbyopia at the Time of Cataract Surgery
View these presentations on presbyopia treatment from the 2023 ASCRS Annual Meeting.
ASCRS Consensus Statement on Vuity
Leads: Douglas Rhee, MD, Cathleen McCabe, MD, Leon Herndon, MD, Rajesh Rao, MD
On August 16, 2022, the Prescribing Information for VUITY (pilocarpine hydrochloride ophthalmic solution) 1.25% was updated following a voluntary submission by Allergan, an AbbVie company, to the U.S. Food and Drug Administration (FDA). New information has now been included in the Warnings and Precautions, Postmarketing Experience, and Patient Counseling Information sections. This ASCRS Task Force was convened to develop an understanding of the data and a preliminary consensus on appropriate counseling of patients regarding risks associated with the use of VUITY.Learn More
In-Depth Instructional Courses
View these presbyopia courses from the 2023 and 2022 ASCRS Annual Meetings.
(Meeting registration required to view 2023 courses)